Scientists may have found a way to keep your bones strong for life

Key Points:

• Researchers at Leipzig University have identified the receptor GPR133, part of the adhesion GPCR family, as a critical regulator of bone strength and density, with dysfunction linked to osteoporosis-like conditions in mice.
• The compound AP503, discovered via computer-assisted screening, stimulates GPR133 and has been shown to significantly increase bone strength in both healthy and osteoporotic mice by promoting bone formation and reducing bone breakdown.
• GPR133 activation balances the activity of osteoblasts and osteoclasts, cells responsible for bone building and resorption, making it a promising target for therapies aimed at rebuilding bone rather than just slowing bone loss.
• Beyond bone health, activating GPR133 with AP503 also improves skeletal muscle strength, suggesting potential dual benefits for aging populations by reducing risks of falls, fractures, and loss of independence.
• This discovery stems from over a decade of research on adhesion GPCRs at Leipzig University and could lead to new treatments that maintain or restore bone and muscle strength, addressing the silent progression of osteoporosis before fractures occur.